MSAB, a β-catenin inhibitor, was identified using cell-based chemical screening
MSAB inhibits growth of Wnt/β-catenin-dependent cancer cells in vitro and in vivo
MSAB disrupts β-catenin activity by prompting proteasomal degradation of β-catenin
MSAB binds to β-catenin